JPH0528687B2 - - Google Patents
Info
- Publication number
- JPH0528687B2 JPH0528687B2 JP25318684A JP25318684A JPH0528687B2 JP H0528687 B2 JPH0528687 B2 JP H0528687B2 JP 25318684 A JP25318684 A JP 25318684A JP 25318684 A JP25318684 A JP 25318684A JP H0528687 B2 JPH0528687 B2 JP H0528687B2
- Authority
- JP
- Japan
- Prior art keywords
- substance
- weight
- present
- administration
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000004480 active ingredient Substances 0.000 claims description 4
- 239000002246 antineoplastic agent Substances 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 2
- 239000000126 substance Substances 0.000 description 13
- 206010028980 Neoplasm Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 238000009472 formulation Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 241000282412 Homo Species 0.000 description 2
- 208000006268 Sarcoma 180 Diseases 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 210000001099 axilla Anatomy 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000723 toxicological property Toxicity 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25318684A JPS61130216A (ja) | 1984-11-30 | 1984-11-30 | 抗腫瘍剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25318684A JPS61130216A (ja) | 1984-11-30 | 1984-11-30 | 抗腫瘍剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61130216A JPS61130216A (ja) | 1986-06-18 |
| JPH0528687B2 true JPH0528687B2 (fr) | 1993-04-27 |
Family
ID=17247741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP25318684A Granted JPS61130216A (ja) | 1984-11-30 | 1984-11-30 | 抗腫瘍剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61130216A (fr) |
-
1984
- 1984-11-30 JP JP25318684A patent/JPS61130216A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61130216A (ja) | 1986-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0430924B2 (fr) | ||
| RU2002101622A (ru) | Нафтохиноновые производные и их использование для лечения и борьбы с туберкулезом | |
| JPH0528687B2 (fr) | ||
| JPH0324446B2 (fr) | ||
| EP0283065A1 (fr) | Associations de FU et BVU comme agents antiadénocarcinomes | |
| JPH0442368B2 (fr) | ||
| JPH0548207B2 (fr) | ||
| JPH0528704B2 (fr) | ||
| JPH0425933B2 (fr) | ||
| JPH0559892B2 (fr) | ||
| JPH0649648B2 (ja) | 酢酸誘導体を含有する抗腫瘍剤 | |
| JPH07277964A (ja) | 抗腫瘍剤 | |
| JPH0735329B2 (ja) | 酢酸誘導体を含有する抗腫瘍剤 | |
| EP0005074A1 (fr) | Matière et composition pour réduire la pression sanguine | |
| JPH072633B2 (ja) | 酢酸誘導体を含有する抗腫瘍剤 | |
| JPH072634B2 (ja) | 酢酸誘導体を含有する抗腫瘍剤 | |
| JPH03502802A (ja) | 抗嘔吐性エルゴリン誘導体 | |
| JPH0344049B2 (fr) | ||
| JPH0528690B2 (fr) | ||
| JPH06135836A (ja) | コントラサプレッサー細胞の誘導剤 | |
| JPS61130224A (ja) | 抗腫瘍剤 | |
| JPS61129128A (ja) | 抗腫瘍剤 | |
| JPH0329766B2 (fr) | ||
| JPS61129121A (ja) | 抗腫瘍剤 | |
| JP2816499B2 (ja) | 糖尿病治療剤 |